BSACI Guidelines for the Management of Allergic and Non-allergic Rhinitis

Overview

Journal Clin Exp Allergy

Specialty Allergy & Immunology

Date 2007 Dec 18

PMID 18081563

Citations 64

Authors

G K Scadding

S R Durham

R Mirakian

N S Jones

S C Leech

S Farooque

D Ryan

S M Walker

A T Clark

T A Dixon

S R A Jolles

N Siddique

P Cullinan

P H Howarth

S M Nasser

Affiliations

Soon will be listed here.

Abstract

This guidance for the management of patients with allergic and non-allergic rhinitis has been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is for use by both adult physicians and paediatricians practicing in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a web-based system. Their comments and suggestions were carefully considered by the SOCC. Where evidence was lacking, consensus was reached by the experts on the committee. Included in this guideline are clinical classification of rhinitis, aetiology, diagnosis, investigations and management including subcutaneous and sublingual immunotherapy. There are also special sections for children, co-morbid associations and pregnancy. Finally, we have made recommendations for potential areas of future research.

Citing Articles

The Potential Role of Nasal Cytology in Respiratory Diseases: Clinical Research and Future Perspectives.

Marcuccio G, Raffio G, Ambrosino P, Candia C, Cantone E, Detoraki A J Clin Med. 2025; 14(3).

PMID: 39941555 PMC: 11818278. DOI: 10.3390/jcm14030884.

Aerobiology matters: Why people in the community access pollen information and how they use it.

Medek D, Katelaris C, Milic A, Beggs P, Lampugnani E, Vicendese D Clin Transl Allergy. 2025; 15(1):e70031.

PMID: 39856010 PMC: 11761002. DOI: 10.1002/clt2.70031.

The Efficacy of Elonide Nasal Corticosteroids in Managing Allergic Rhinitis: A Randomized, Double-Blinded Trial.

Gendeh H, Hamizan A, Husain S, Nawi A, Zahedi F, Megat Ismail N J Clin Med. 2024; 13(7).

PMID: 38610648 PMC: 11012514. DOI: 10.3390/jcm13071883.

A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis.

Kumar B, Deshmukh R Curr Pharm Des. 2024; 30(12):887-901.

PMID: 38486383 DOI: 10.2174/0113816128295952240306072100.

Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT.

Carrie S, Fouweather T, Homer T, OHara J, Rousseau N, Rooshenas L Health Technol Assess. 2024; 28(10):1-213.

PMID: 38477237 PMC: 11017631. DOI: 10.3310/MVFR4028.

References

Shusterman D . Toxicology of nasal irritants. Curr Allergy Asthma Rep. 2003; 3(3):258-65. DOI: 10.1007/s11882-003-0048-z. View

Johnson S, Marion A, Vrchoticky T, Emmanuel P, Lujan-Zilbermann J . Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr. 2006; 148(3):386-8. DOI: 10.1016/j.jpeds.2005.11.034. View

Gwaltney Jr J . Acute community acquired bacterial sinusitis: To treat or not to treat. Can Respir J. 1999; 6 Suppl A:46A-50A. View

Passalacqua G, Ciprandi G, Pasquali M, Guerra L, Canonica G . An update on the asthma-rhinitis link. Curr Opin Allergy Clin Immunol. 2004; 4(3):177-83. DOI: 10.1097/00130832-200406000-00007. View

Pullerits T, Praks L, Ristioja V, Lotvall J . Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002; 109(6):949-55. DOI: 10.1067/mai.2002.124467. View

McNeely W, Wiseman L . Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis. Drugs. 1998; 56(1):91-114. DOI: 10.2165/00003495-199856010-00011. View

Gani F, Pozzi E, Crivellaro M, Senna G, Landi M, Lombardi C . The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy. 2001; 56(1):65-8. DOI: 10.1034/j.1398-9995.2001.00794.x. View

Canonica G, Passalacqua G . Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003; 111(3):437-48; quiz 449. DOI: 10.1067/mai.2003.129. View

Larese Filon F, Radman G . Latex allergy: a follow up study of 1040 healthcare workers. Occup Environ Med. 2006; 63(2):121-5. PMC: 2078060. DOI: 10.1136/oem.2003.011460. View

10.

Johnston S, Pattemore P, SANDERSON G, Smith S, Lampe F, Josephs L . Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995; 310(6989):1225-9. PMC: 2549614. DOI: 10.1136/bmj.310.6989.1225. View

11.

Corren J, Adinoff A, Irvin C . Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol. 1992; 89(2):611-8. DOI: 10.1016/0091-6749(92)90329-z. View

12.

Bronsky E, Druce H, Findlay S, Hampel F, Kaiser H, Ratner P . A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995; 95(5 Pt 2):1117-22. DOI: 10.1016/s0091-6749(95)70215-6. View

13.

Hall S . Acute angle-closure glaucoma as a complication of combined beta-agonist and ipratropium bromide therapy in the emergency department. Ann Emerg Med. 1994; 23(4):884-7. DOI: 10.1016/s0196-0644(94)70329-9. View

14.

Kayarkar R, Clifton N, Woolford T . An evaluation of the best head position for instillation of steroid nose drops. Clin Otolaryngol Allied Sci. 2002; 27(1):18-21. DOI: 10.1046/j.1365-2273.2002.00515.x. View

15.

Flanagan P, Eccles R . Spontaneous changes of unilateral nasal airflow in man. A re-examination of the 'nasal cycle'. Acta Otolaryngol. 1997; 117(4):590-5. DOI: 10.3109/00016489709113443. View

16.

Schwarzer G, Bassler D, Mitra A, Ducharme F, Forster J . Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children. Cochrane Database Syst Rev. 2004; (1):CD001384. PMC: 8406918. DOI: 10.1002/14651858.CD001384.pub2. View

17.

Bachert C, Bousquet J, Canonica G, Durham S, Klimek L, Mullol J . Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004; 114(4):838-44. DOI: 10.1016/j.jaci.2004.05.070. View

18.

Gidaro G, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G . The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy. 2005; 35(5):565-71. DOI: 10.1111/j.1365-2222.2005.02240.x. View

19.

Storms W . Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol. 2004; 114(5 Suppl):S146-53. DOI: 10.1016/j.jaci.2004.08.045. View

20.

Adams R, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F . Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol. 2002; 110(1):58-64. DOI: 10.1067/mai.2002.125489. View